TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/10/24 07:30 | 5/8/24 | PSTV | Plus Therapeutics, Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Hawkins Richard J | TX | D | P.d | 10 | 2.04 | 0 | 5 | 999% | 5 | D | |||||||||||||||
3/6/23 19:40 | 3/3/23 | PSTV | Plus Therapeutics, Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Hawkins Richard J | TX | D | P | 1 | 1,000.0 | 0 | 0 | New | 0 | D | |||||||||||||||
9/23/22 17:05 | 9/21/22 | LUMO | Lumos Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hawkins Richard J | TX | DO | CEO | P.m | 21 | 8.84 | 0 | 2 | 0 | 753 | I | ||||||||||||||
9/21/22 18:45 | 9/19/22 | LUMO | Lumos Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hawkins Richard J | TX | DO | CEO | P.m | 18 | 8.72 | 0 | 2 | 0 | 750 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |